Literature DB >> 24267438

Costs, benefits, and effectiveness of interventions for the prevention, treatment, and control of cardiovascular diseases and diabetes in Africa.

Shanthi Mendis1, Oleg Chestnov.   

Abstract

If a combination of cost-effective health-care interventions and population-wide prevention interventions is implemented in a sustainable manner, a significant impact can be made on the cardiovascular disease and diabetes burden. Given the limited resources, weak health systems and competing health issues in Africa, the focus should be on interventions prioritized on the basis not only of cost effectiveness but also of affordability, feasibility and high impact. The Global Action Plan for prevention and control of noncommunicable diseases 2013-2020 identifies such a core set. Financing the effective delivery of this core set as part of the basic health care package through a strengthened health system is a pragmatic approach to address cardiovascular disease and diabetes in Africa. Cost of implementation of this core set of interventions represents an annual investment of under US$ 1 in low income countries, US$ 1.50 in lower middle income countries and US$ 3 in upper middle income countries.
© 2013.

Entities:  

Keywords:  Cardiovascular disease; Cost; Cost effectiveness; Diabetes; NCD; noncommunicable disease

Mesh:

Year:  2013        PMID: 24267438     DOI: 10.1016/j.pcad.2013.09.001

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  5 in total

1.  The global burden of cardiovascular diseases: a challenge to improve.

Authors:  Shanthi Mendis; Oleg Chestnov
Journal:  Curr Cardiol Rep       Date:  2014-05       Impact factor: 2.931

2.  Direct and Indirect Costs of Diabetes in Brazil in 2016.

Authors:  Paula Pereda; Vanessa Boarati; Bruna Guidetti; Ana Clara Duran
Journal:  Ann Glob Health       Date:  2022-03-03       Impact factor: 2.462

3.  New risk-scoring system including non-alcoholic fatty liver disease for predicting incident type 2 diabetes in East China: Shanghai Baosteel Cohort.

Authors:  Guang-Yu Chen; Hai-Xia Cao; Feng Li; Xiao-Bo Cai; Qing-Hong Ao; Yan Gao; Jian-Gao Fan
Journal:  J Diabetes Investig       Date:  2015-08-13       Impact factor: 4.232

4.  Costs and Cost-Effectiveness of Hypertension Screening and Treatment in Adults with Hypertension in Rural Nigeria in the Context of a Health Insurance Program.

Authors:  Nicole T A Rosendaal; Marleen E Hendriks; Mark D Verhagen; Oladimeji A Bolarinwa; Emmanuel O Sanya; Philip M Kolo; Peju Adenusi; Kayode Agbede; Diederik van Eck; Siok Swan Tan; Tanimola M Akande; William Redekop; Constance Schultsz; Gabriela B Gomez
Journal:  PLoS One       Date:  2016-06-27       Impact factor: 3.240

5.  Cost-effectiveness of interventions to control cardiovascular diseases and diabetes mellitus in South Asia: a systematic review.

Authors:  Kavita Singh; Ambalam M Chandrasekaran; Soumyadeep Bhaumik; Kaushik Chattopadhyay; Anuji Upekshika Gamage; Padmal De Silva; Ambuj Roy; Dorairaj Prabhakaran; Nikhil Tandon
Journal:  BMJ Open       Date:  2018-04-03       Impact factor: 2.692

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.